Information Provided By: 
Fly News Breaks for February 7, 2020
CNC
Feb 7, 2020 | 05:10 EDT
Goldman Sachs analyst Stephen Tanal reinstated coverage of Centene with a Buy rating and $80 price target. The company's acquisition of WellCare will be slightly accretive to adjusted earnings in year one and produce mid-to-high single digit percentage accretion in year two, Tanal tells investors in a research note. He believes Centene's multi-year earnings growth is underappreciated at current share levels.
News For CNC From the Last 2 Days
There are no results for your query CNC
